Programming of the development of tumor-promoting neutrophils by mesenchymal stromal cells

Cellular Physiology and Biochemistry

Volumn 33, Issue 6, 2014, Pages 1802-1814

  Hu, Xiaoyu ^a   Zhou, Yushan ^b   Dong, Kui ^c   Sun, Zhina ^a   Zhao, Dan ^a   Wang, Weiqiang ^c   Yu, Gang ^b   Liu, Wentian ^c   Xu, Guogang ^b,d   Han, Zhongchao ^a   Feng, Xiaoming ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b NANCHANG UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Immunosuppressive; Mesenchymal stromal cells; Neutrophils; Tumor

Indexed keywords

ARGINASE; CD11B ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BREAST TUMOR; CELL ISOLATION; COCULTURE; CONTROLLED STUDY; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STROMA CELL; MOLECULAR MODEL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN TUMOR; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; UPREGULATION; BONE MARROW CELL; CELL PROLIFERATION ASSAY; ENZYME ACTIVITY; ENZYME INHIBITION; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; CELL COMMUNICATION; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; DNA MICROARRAY; EXPERIMENTAL MAMMARY NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

MUS;

ANIMALS; ARGINASE; BONE MARROW CELLS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOPHENOTYPING; MAMMARY NEOPLASMS, EXPERIMENTAL; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUMOR BURDEN;

EID: 84902022927     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362959     Document Type: Article

References (29)

1. English K, French A, Wood KJ: Mesenchymal stromal cells: Facilitators of successful transplantation? Cell Stem Cell 2010;7:431-442.
2. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'Ayan A, Enikolopov GN, Frenette PS: Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466:829-834.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
4. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
5. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D: Carcinoma-Associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008;68:4331-4339.
6. Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S, Baik GH, Shibata W, Diprete B, Betz KS, Friedman R, Varro A, Tycko B, Wang TC: Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011;19:257-272.
7. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F: Mesenchymal stem cell transition to tumor-Associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009;4:e4992.
8. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M: Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004;96:1593-1603.
9. Ren G, Zhao X, Wang Y, Zhang X, Chen X, Xu C, Yuan ZR, Roberts AI, Zhang L, Zheng B, Wen T, Han Y, Rabson AB, Tischfield JA, Shao C, Shi Y: CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFalpha. Cell Stem Cell 2012;11:812-824.
10. Eggenhofer E, Hoogduijn MJ: Mesenchymal stem cell-educated macrophages. Transplant Res 2012;1:12.
11. Nathan C: Neutrophils and immunity: Challenges and opportunities. Nat Rev Immunol 2006;6:173-182.
12. Koenderman L, Yazdanbakhsh M, Roos D, Verhoeven AJ: Dual mechanisms in priming of the chemoattractant-induced respiratory burst in human granulocytes. A Ca2+-dependent and a Ca2+-independent route. J Immunol 1989;142:623-628.
13. Hakansson L, Venge P: Priming of eosinophil and neutrophil migratory responses by interleukin 3 and interleukin 5. Apmis 1994;102:308-316.
14. Matsushima H, Geng S, Lu R, Okamoto T, Yao Y, Mayuzumi N, Kotol PF, Chojnacki BJ, Miyazaki T, Gallo RL, Takashima A: Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells. Blood 2013;121:1677-1689.
15. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM: Polarization of tumor-Associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009;16:183-194.
16. Pillay J, Tak T, Kamp VM, Koenderman L: Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: Similarities and differences. Cell Mol Life Sci 2013;70:3813-3827.
17. Cassatella MA, Mosna F, Micheletti A, Lisi V, Tamassia N, Cont C, Calzetti F, Pelletier M, Pizzolo G, Krampera M: Toll-like receptor-3-Activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils. Stem Cells 2011;29:1001-1011.
18. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ: Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
19. Urban VS, Kiss J, Kovacs J, Gocza E, Vas V, Monostori E, Uher F: Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008;26:244-253.
20. Feng X, Ippolito GC, Tian L, Wiehagen K, Oh S, Sambandam A: L Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood 2010;115:510-518
21. Rodriguez PC, Quiceno DG, Ochoa AC: L-Arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007;109:1568-1573.
22. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S, Aburatani H, Maru Y: The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 2008;10:1349-1355.
23. Raber PL, Thevenot P, Sierra R, Wyczechowska D, Halle D, Ramirez ME, Ochoa A, Fletcher M, Velasco C, Wilk A, Reiss K, Rodriguez PC: Subpopulations of Myeloid-Derived Suppressor Cells (MDSC) impair T cell responses through independent nitric oxide-related pathways. Int J Cancer 2014;134:2853-2864.
24. Zarogoulidis P, Yarmus L, Darwiche K, Walter R, Huang H, Li Z, Zaric B, Tsakiridis K, Zarogoulidis K: Interleukin-6 cytokine: A multifunctional glycoprotein for cancer. Immunome Res 2013;9:16535.
25. Noel G, Wang Q, Schwemberger S, Hanson C, Giacalone N, Haar L, Ogle CK: Neutrophils, not monocyte/macrophages, are the major splenic source of postburn IL-10. Shock 2011;36:149-155.
26. De Santo C, Arscott R, Booth S, Karydis I, Jones M, Asher R, Salio M, Middleton M, Cerundolo V: Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid a. Nat Immunol 2010;11:1039-1046.
27. Davey MS, Tamassia N, Rossato M, Bazzoni F, Calzetti F, Bruderek K, Sironi M, Zimmer L, Bottazzi B, Mantovani A, Brandau S, Moser B, Eberl M, Cassatella MA: Failure to detect production of IL-10 by activated human neutrophils. Nat Immunol 2011;12:1017-1018, 1018-1020.
28. Sinha P, Clements VK, Ostrand-Rosenberg S: Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res 2005;65:11743-11751.
29. Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA: Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence. J Exp Med 2003;198:1741-1752.